Celldex Therapeutics, Inc. is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

View all →   RSSRecent Releases
Jul 2, 2015 Celldex Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
Jul 1, 2015 Celldex Therapeutics Appoints Richard Wright as Chief Commercial Officer
What's New

2012 Form 10-K

More →Upcoming Events
Jul 8, 2015
8:30 AM ET
Cantor Fitzgerald Inaugural Healthcare Conference
Featured Financial Reports
Filing Date Title Type Size
Apr 29, 2015 Form 10-Q View HTML View PDF 312.8 KB Add to Briefcase
Feb 24, 2015 Form 10-K View HTML View PDF 1.1 MB Add to Briefcase
Add to Briefcase = add file to Briefcase